Table 1. Clinical characteristics of the 22 hepatocellular carcinoma (HCC) patients.
| Age: mean | 49 ± 13.5 |
| range | 35.5–62.5 |
| Sex: male/female | 21/1 |
| Aspartate aminotransferase (U/L) | 100.5 ± 65.8 |
| Alanine aminotransferase (U/L) | 85.6 ± 95.6 |
| Alkaline Phosphatase (U/L) | 110.2 ± 60.7 |
| Serum albumin (g/dL) | 4.6 ± 1.5 |
| Serum alpha-fetoprotein (ng/mL) | 155.7 ± 22.3 |
| HCV statusa | 100% (22 HCC patients) |
| HBV statusb | 18.2% (4/22 HCC patients) |
a
HCV status was determined using anti-HCV antibody and/or HCV viral RNA quantification.
b
HBV status was determined using anti-HBc and anti-HBs antibodies and by detection of HBsAg.